Related Experiment Video

Updated: Jul 21, 2025

Bioluminescent Bacterial Imaging In Vivo
05:06

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

15.4K

Cancer Drug Delivery Systems Using Bacterial Toxin Translocation Mechanisms

Linxiang Yin1,2,3, Hatim Thaker1,2,3

  • 1Department of Urology, Boston Children's Hospital, Boston, MA 02115, USA.

Bioengineering (Basel, Switzerland)
|July 29, 2023
PubMed

Insights

Bacterial toxins offer a novel approach for targeted cancer therapy drug delivery by mimicking their natural cell-entry mechanisms. This review explores toxin-inspired systems for improved cancer treatment, addressing current limitations.

Area of Science:

  • Biotechnology and Biomedical Engineering
  • Molecular Biology and Biochemistry
  • Cancer Therapeutics

Background:

  • Targeted cancer therapies require efficient intracellular drug delivery, a challenge for traditional systems.
  • Existing methods often necessitate high drug doses, leading to adverse effects.
  • Bacterial toxins possess natural mechanisms for specific cell targeting and membrane translocation.

Purpose of the Study:

  • To review bacterial toxin translocation mechanisms for drug delivery applications.
  • To highlight recent advancements in cancer therapy drug delivery systems inspired by bacterial toxins.
  • To discuss challenges and future directions for bacterial toxin-based drug delivery.

Main Methods:

  • Review of scientific literature on bacterial toxin mechanisms (anthrax toxin, diphtheria toxin, Pseudomonas exotoxin A).
  • Analysis of engineered drug delivery systems utilizing toxin-inspired receptor binding and membrane translocation.
  • Discussion of preclinical and clinical research progress in toxin-based cancer therapy.

Main Results:

  • Bacterial toxins provide effective models for receptor-mediated targeting and cytosol delivery.
  • Toxin-inspired systems demonstrate potential for enhanced drug delivery across cell membranes.
  • Several studies show promise in adapting these mechanisms for targeted cancer drug delivery.

Conclusions:

  • Bacterial toxin translocation mechanisms offer a promising strategy for developing next-generation cancer drug delivery systems.
  • Further research is needed to overcome challenges for successful clinical translation.
  • Toxin-inspired delivery holds potential for more effective and safer cancer treatments.
Keywords:
bacterial toxincancer therapydrug deliveryimmunotoxinstranslocation mechanism

More Related Videos

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

13.6K
Electroporation of Functional Bacterial Effectors into Mammalian Cells08:39

Electroporation of Functional Bacterial Effectors into Mammalian Cells

Published on: January 19, 2015

10.1K

Related Concept Videos

Bacterial Translocation and Protein Secretion01:26

Bacterial Translocation and Protein Secretion

Bacterial protein secretion involves translocation systems to ensure proteins reach their designated locations, including the plasma membrane, periplasm, outer membrane, or the external environment. These translocation systems are vital for bacterial physiology, supporting processes like membrane assembly, enzymatic activity in the periplasm, and interactions with the external environment. The division of labor between Sec and Tat pathways ensures efficiency in handling proteins with diverse...
39
Gram-negative Bacterial Protein Secretion Systems01:17

Gram-negative Bacterial Protein Secretion Systems

Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
47
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
42
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
6.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
470